AFib impacts between 1% and 2% of the global population. The lifetime risk of developing AFib is around one in four for individuals >40-years, and one in six for individuals without a prior or concurrent history of myocardial infarction or congestive heart failure (HF). Prevalence increases with age, reaching ~10% in individuals >75-years.1
According to Stambler et al, the prevalence of AFib is lower in Africa compared to developed countries but will increase significantly in the...